Welcome to LookChem.com Sign In|Join Free

CAS

  • or

78324-14-8

Post Buying Request

78324-14-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

78324-14-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 78324-14-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,3,2 and 4 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 78324-14:
(7*7)+(6*8)+(5*3)+(4*2)+(3*4)+(2*1)+(1*4)=138
138 % 10 = 8
So 78324-14-8 is a valid CAS Registry Number.

78324-14-8Relevant articles and documents

Directing the crystallization of dehydro[24]annulenes into supramolecular nanotubular scaffolds

Suzuki, Mitsuharu,Kotyk, Juliet F. Khosrowabadi,Khan, Saeed I.,Rubin, Yves

, p. 5939 - 5956 (2016)

The self-assembly of a series of dehydro[24]annulene derivatives into columnar stacks has been examined for its latent ability to form -conjugated carbon-rich nanotubular structures through topochemical polymerizations. We have studied the parameters affe

COMPOSITIONS AND METHODS FOR MAKING HYBRID POLYPEPTIDES

-

Page/Page column 107, (2020/12/29)

Compositions and methods of making hybrid polypeptides and other polymers are disclosed. For example, functionalized tRNA having a functional molecule including a benzoic acid or benzoic acid derivative acylated to the 3' nucleotide of a tRNA are provided

Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with gram-positive antibacterial activity

O'Daniel, Peter I.,Peng, Zhihong,Pi, Hualiang,Testero, Sebastian A.,Ding, Derong,Spink, Edward,Leemans, Erika,Boudreau, Marc A.,Yamaguchi, Takao,Schroeder, Valerie A.,Wolter, William R.,Llarrull, Leticia I.,Song, Wei,Lastochkin, Elena,Kumarasiri, Malika,Antunes, Nuno T.,Espahbodi, Mana,Lichtenwalter, Katerina,Suckow, Mark A.,Vakulenko, Sergei,Mobashery, Shahriar,Chang, Mayland

, p. 3664 - 3672 (2014/03/21)

Infections caused by hard-to-treat methicillin-resistant Staphylococcus aureus (MRSA) are a serious global public-health concern, as MRSA has become broadly resistant to many classes of antibiotics. We disclose herein the discovery of a new class of non-β-lactam antibiotics, the oxadiazoles, which inhibit penicillin-binding protein 2a (PBP2a) of MRSA. The oxadiazoles show bactericidal activity against vancomycin-and linezolid-resistant MRSA and other Gram-positive bacterial strains, in vivo efficacy in a mouse model of infection, and have 100% oral bioavailability.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 78324-14-8